XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.4
Net Earnings (Loss) per Share
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Loss per common share:    
Net Earnings (Loss) per Share

16. Net Earnings (Loss) per Share

 

The Company uses the two-class method to calculate net income (loss) per share. No dividends were declared or paid for the three and nine months ended September 30, 2024 and 2023. Undistributed earnings for each period are allocated equally to common shareholders and participating securities based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. Under the two-class method, the undistributed losses will be allocated entirely to the common stock shareholders. Basic net earnings (loss) per common share are calculated by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing net income (loss) by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock-based awards based on the treasury stock method.

 

In periods where a net loss is recorded, no effect is given to potentially dilutive securities, since the effect would be anti-dilutive.

 

The following table sets forth the computation of the Company’s basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share data):

 

                 
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2024   2023   2024   2023 
Net loss  $(5,669)  $(6,342)  $(16,363)  $(23,657)
Weighted average common shares outstanding, basic and diluted   5,773,993    1,366,842    4,833,091    1,346,264 
Net loss per share, basic and diluted  $(0.98)  $(4.64)  $(3.39)  $(17.57)

 

 

The following table sets forth the securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future:

 

September 30,  2024   2023 
Common stock warrants   2,269,356    459,856 
Common stock options and RSUs   1,775,444    82,719 
Unit Purchase Options   20,182    20,812 
Shares related to Series B-2 convertible preferred stock   6,636,981    - 
Shares related to Series B-3 convertible preferred stock   10,026,859    - 
Total   20,728,822    563,387 

 

Common Stock warrants include Purchase Warrants, Inducement Warrants and warrants issued in the Company’s initial public offering.

 

22. Net Loss per Share

 

Basic net earnings (loss) per common share are calculated by dividing net income by the weighted average number of common shares outstanding during the period. As noted in ASC 260-10-45-13, shares issuable for little to no consideration should be included in the number of outstanding shares used for basic EPS. As such, the 2022 Pre-Funded Warrants are included in the outstanding shares for EPS purposes. Diluted net earnings per common share are calculated by dividing net income (loss) by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock-based awards based on the treasury stock method. In periods where a net loss is recorded, no effect is given to potentially dilutive securities, since the effect would be anti-dilutive.

 

The following table sets forth the computation of the Company’s basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share data):

 

   2023   2022 
   For years ended December 31, 
   2023   2022 
Net loss  $(20,131)  $(640)
Weighted average common shares outstanding, basic and diluted   1,546,297    1,056,988 
Net loss per share, basic and diluted  $(13.02)  $(0.61)

 

The following table sets forth securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future:

 

December 31,  2023   2022 
Common stock warrants   2,269,356    459,856 
Common stock options and RSUs   104,257    104,127 
Unit Purchase Options   20,182    20,182 
Total   2,393,795    584,165